Sweetgreen, Inc. Earnings Per Share Disclosure
| (dollar amounts in thousands) | Fiscal Year Ended December 28, 2025 | Fiscal Year Ended December 29, 2024 | Fiscal Year Ended December 31, 2023 | ||||||||||||||
Numerator: | |||||||||||||||||
Net loss | $ | (134,065) | $ | (90,373) | $ | (113,384) | |||||||||||
Denominator: | |||||||||||||||||
Weighted-average common shares outstanding—basic and diluted | 117,956,165 | 114,321,672 | 111,907,675 | ||||||||||||||
Earnings per share—basic and diluted | $ | (1.14) | $ | (0.79) | $ | (1.01) | |||||||||||
Fiscal Year Ended December 28, 2025 | Fiscal Year Ended December 29, 2024 | Fiscal Year Ended December 31, 2023 | |||||||||||||||
| Options to purchase common stock | 14,070,559 | 13,169,869 | 13,219,388 | ||||||||||||||
| Time-based vesting restricted stock units | 783,226 | 910,024 | 951,517 | ||||||||||||||
| Performance stock units | 4,500,000 | 4,500,000 | 6,621,428 | ||||||||||||||
| Contingently issuable stock | 250,000 | 500,000 | 714,285 | ||||||||||||||
Total common stock equivalents | 19,603,785 | 19,079,893 | 21,506,618 | ||||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.